Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $188,955 - $219,249
1,700 Added 1.2%
143,600 $16.3 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $97 Million - $104 Million
-783,400 Reduced 84.66%
141,900 $17.6 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $92.2 Million - $107 Million
813,800 Added 729.87%
925,300 $122 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $5.85 Million - $6.37 Million
58,400 Added 109.98%
111,500 $12.2 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $5.77 Million - $6.29 Million
53,100 New
53,100 $6.13 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $1.47 Million - $1.88 Million
-16,800 Reduced 32.25%
35,300 $3.92 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $12.6 Million - $14.2 Million
-149,400 Reduced 74.14%
52,100 $4.49 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $5.95 Million - $6.75 Million
-71,300 Reduced 26.14%
201,500 $18.4 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $19.3 Million - $21.6 Million
262,500 Added 2548.54%
272,800 $22.4 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $332,488 - $416,484
4,600 Added 80.7%
10,300 $789,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $179,200 - $197,075
2,500 Added 78.13%
5,700 $428,000
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $393,736 - $435,512
-5,600 Reduced 63.64%
3,200 $249,000
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $110,176 - $129,776
1,600 Added 22.22%
8,800 $678,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $279,903 - $310,635
3,900 Added 118.18%
7,200 $589,000
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $43,908 - $49,770
600 Added 22.22%
3,300 $274,000
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $147,882 - $168,273
-2,100 Reduced 43.75%
2,700 $209,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $372,384 - $420,192
4,800 New
4,800 $437,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.